CN1679981A - Medicine composition for treating beriberi - Google Patents
Medicine composition for treating beriberi Download PDFInfo
- Publication number
- CN1679981A CN1679981A CN 200510009710 CN200510009710A CN1679981A CN 1679981 A CN1679981 A CN 1679981A CN 200510009710 CN200510009710 CN 200510009710 CN 200510009710 A CN200510009710 A CN 200510009710A CN 1679981 A CN1679981 A CN 1679981A
- Authority
- CN
- China
- Prior art keywords
- parts
- effect
- beriberi
- sulfur
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
A composite medicine for treating beriberi is prepared from camphor, sulfur, calomelas, metacortadracin, salicylic acid, borneol and vaseline.
Description
Technical field:
The present invention relates to the used a kind of pharmaceutical composition of medical technical field, belong to a kind of pharmaceutical composition for the treatment of beriberi.
Background technology:
Beriberi is a kind of commonly encountered diseases, stubborn disease, beriberi is commonly called as tinea pedis again, is the fungal infection of the shallow portion of a kind of toe mesothelium, and common symptom has following four types: (1) hyperkeratotic pattern, skin lesion often is positioned at the vola winter owing to hyperkeratosis causes pachyderma, coarse; (2) blister type, blister often is positioned at the vola, and wall thickness and be difficult for breaking in groups or be dispersed in branch, often has pruritus, if the secondary bacterial infection then becomes pustule; (3) dipping erosive type, the deliquescing that bleaches is flooded at the skin place through moisture, exposes red rotten to the corn face after wiping epidermis, foul smelling, play is itched unbearably, and the patient often scratches and the secondary bacterial infection; (4) pimple squama type, skin lesion are positioned at vola, sufficient edge and heel etc. to be located, and shows as erythema and mound to examine, and there is tangible strip desquamation on the surface, the likeness in form tinea corporis.At present the medicine of treatment is varied, comprise medicines such as Chinese medicine, Western medicine, Chinese medicine and western medicine combination, but therapeutic effect is not obvious, outbreak repeatedly commonly, and general has been showed effect again in several days, was difficult to effect a radical cure.
Summary of the invention:
Can not effect a radical cure in order to solve existing beriberi, the problem of outbreak repeatedly, the invention provides a kind of pharmaceutical composition for the treatment of beriberi, this pharmaceutical composition has short treating period, instant effect, characteristics that cure rate is high to vitamin B1 deficiency.
The technical solution adopted in the present invention is: the pharmaceutical composition of this treatment beriberi, make by weight by following raw materials according: 2～10 parts of Camphoras, 10～30 parts in sulfur, 1～10 part of Calomelas, 0.1～0.2 part of meticorten sheet, 1～5 part of salicylic acid, 1～10 part of Borneolum Syntheticum, 50～100 parts in vaseline.
5 parts of above-mentioned Camphoras, 20 parts in sulfur, 4 parts of Calomelass, 0.15 part of meticorten sheet, 2 parts of salicylic acid, 4 parts of Borneolum Syntheticums, 80 parts in vaseline.
The invention has the beneficial effects as follows: the medicament that adopts such scheme to be mixed with, this medicament has antifungal, killing parasites for relieving itching, reducing swelling and alleviating pain, removes the function of stubborn dermatitis and merit poison erosion poison, can cure in beriberi 1-3 days for hyperkeratotic pattern, blister type, pimple squama type, can cure in 5-7 days for the dipping erosive type, no side effects is not hindered skin, no sensation of pricking, cure and not stay root, and have short treating period, cure rate height, characteristics easy to use.
The specific embodiment:
Below with the invention will be further described:
The pharmaceutical composition of this treatment beriberi is made by weight by following raw materials according: 2～10 parts of Camphoras, 10～30 parts in sulfur, 1～10 part of Calomelas, 0.1～0.2 part of meticorten sheet, 1～5 part of salicylic acid, 1～10 part of Borneolum Syntheticum, 50～100 parts in vaseline.Preferably: 5 parts of Camphoras, 20 parts in sulfur, 4 parts of Calomelass, 0.15 part of meticorten sheet, 2 parts of salicylic acid, 4 parts of Borneolum Syntheticums, 80 parts in vaseline.In the said medicine the first six planted after medicine becomes smalls by its proportioning mixed grinding, can make this medicine with vaseline furnishing paste.
Camphora in this medicine is that monarch drug has another name called camphor, tree brain etc., root for the canella Camphor tree, do, branch, white crystalline powder or colourless translucent granular substance or piece sheet that the Ye Jing distillation is refined into, acrid in the mouth, hot in nature, GUIXIN, spleen channel, slightly poisonous, this Camphora has orifice opening, qi stagnation removing, ward off foul, killing parasites for relieving itching, the curative effect of reducing swelling and alleviating pain, be applied to skin gentle stimulation and antisepsis are arranged, and slight anesthetic action arranged, the consumption of this Camphora is too much unsuitable, consumption too much produces zest to skin, consumption is also unsuitable very few, very few DeGrain or do not have effect; Sulfur is ministerial drug, different name Cosan, stone sulfur etc., has supplementing the fire of vital gate to invigo rate YANG, warming the spleen relieving constipation, the effect of killing parasites for relieving itching, simultaneously poisonous, this sulfur can end stubborn dermatitis in the present invention, and warm malicious malignant boil has dissolving cutin, antifungal and antiparasitic effect, simultaneously seborrhea can be prevented, and the effect of principal agent can be strengthened.Prednisone is a Western medicine, is glucocorticoid, has antiphlogistic effect, and effect is 3-5 a times of cortisone, cooperates monarch drug to strengthen the effect of antiinflammatory, antiallergic; Calomelas is that adjuvant drug claims CALOMELAS, hydrargyrum powder again, have effects such as counteracting toxic substances erosion poison, killing parasites for relieving itching, to carbuncle hold back infections, fester have an itch, the bright poison of heat clearing away, infections is held back in damp eliminating that effect is preferably arranged, this flavour of a drug suffering, cold in nature poisonous, consumption is few among the we, have no side effect, and can cooperate monarch drug, accessory drugs to strengthen therapeutical effect; Salicylic acid is the Western medicine powder, is broad spectrum antibiotic, and the cymbidium positive, negative bacteria, pathogenic yeast, dermatophytosis are had antibacterial action, has no side effect; Borneolum Syntheticum is that messenger drug claims Borneolum Syntheticum, borneol etc. again, has effects such as the refreshment of having one's ideas straightened out, heat radiation pain relieving, and the messenger drug effect of analgesia, elimination abnormal flavour is arranged in the present invention; The effect that have antifungal, killing parasites for relieving itching after the above-mentioned various medicine combination, removes stubborn dermatitis.As seen, this medicament preparation is simple, and cost is low, and usage is convenient, and evident in efficacy, the cure rate height can be eradicated disease, has no side effect, and can promote the use of.
Embodiment 1, Camphora 2 gram, sulfur 10 grams, Calomelas 1 gram, meticorten sheet 0.1 gram, salicylic acid 1 gram, Borneolum Syntheticum 1 gram mixed grinding become smalls after, restrain the furnishing pastes with vaseline 50 and can make this medicine.Using method: with this unguentum medicine external application affected part, every day 1-2 time.
Embodiment 2, Camphora 5 gram, sulfur 20 grams, Calomelas 4 grams, meticorten sheet 0.15 gram, salicylic acid 2 grams, Borneolum Syntheticum 4 gram mixed grindings are become smalls after, restrain the furnishing pastes with vaseline 80 and can make this medicine.Using method: with this unguentum medicine external application affected part, every day 1-2 time.
Embodiment 3, Camphora 10 gram, sulfur 30 grams, Calomelas 10 grams, meticorten sheet 0.2 gram, salicylic acid 5 grams, Borneolum Syntheticum 10 gram mixed grindings are become smalls after, restrain the furnishing pastes with vaseline 100 and can make this medicine.Using method: with this unguentum medicine external application affected part, every day 1-2 time.
Claims (2)
1, a kind of pharmaceutical composition for the treatment of beriberi is characterized in that: made by weight by following raw materials according: 2～10 parts of Camphoras, 10～30 parts in sulfur, 1～10 part of Calomelas, 0.1～0.2 part of meticorten sheet, 1～5 part of salicylic acid, 1～10 part of Borneolum Syntheticum, 50～100 parts in vaseline.
2, the pharmaceutical composition of treatment beriberi according to claim 1 is characterized in that: 5 parts of Camphoras, 20 parts in sulfur, 4 parts of Calomelass, 0.15 part of meticorten sheet, 2 parts of salicylic acid, 4 parts of Borneolum Syntheticums, 80 parts in vaseline.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100097101A CN100356910C (en) | 2005-02-02 | 2005-02-02 | Medicine composition for treating beriberi |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2005100097101A CN100356910C (en) | 2005-02-02 | 2005-02-02 | Medicine composition for treating beriberi |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1679981A true CN1679981A (en) | 2005-10-12 |
| CN100356910C CN100356910C (en) | 2007-12-26 |
Family
ID=35066966
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB2005100097101A Expired - Fee Related CN100356910C (en) | 2005-02-02 | 2005-02-02 | Medicine composition for treating beriberi |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100356910C (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105688197A (en) * | 2016-03-11 | 2016-06-22 | 浙江艾杰斯生物科技有限公司 | Beriberi treatment drug containing lysozyme |
| CN113797223A (en) * | 2020-06-17 | 2021-12-17 | 徐旺 | Ointment for treating beriberi |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1096212A (en) * | 1993-12-16 | 1994-12-14 | 吴海平 | A kind of medicine for the treatment of tinea pedis |
| CN1086125C (en) * | 1999-08-02 | 2002-06-12 | 张延亭 | Externally used medicine for treating tinea |
| CN1241578C (en) * | 2003-07-22 | 2006-02-15 | 马柏林 | Skin-care medicine with functions of relieving-itching, fully eliminating-toxins and curing-tinea, and its prepn. method |
-
2005
- 2005-02-02 CN CNB2005100097101A patent/CN100356910C/en not_active Expired - Fee Related
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105688197A (en) * | 2016-03-11 | 2016-06-22 | 浙江艾杰斯生物科技有限公司 | Beriberi treatment drug containing lysozyme |
| CN113797223A (en) * | 2020-06-17 | 2021-12-17 | 徐旺 | Ointment for treating beriberi |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100356910C (en) | 2007-12-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP0988040B1 (en) | Use of glucosamine and glucosamine derivatives for quick alleviation of itching or localized pain | |
| CN104940297B (en) | A kind of Chinese medicine nasal cavity anti-inflammatory preparation and preparation method thereof | |
| CN100356910C (en) | Medicine composition for treating beriberi | |
| CN104873446A (en) | Cinnamon oil containing toothpaste | |
| CN109464621A (en) | A kind of external preparation and preparation method thereof for treating eczema | |
| CN102743587A (en) | External application wound repair liquid | |
| CN102885969B (en) | Externally applied cream for treating toothache caused by deficiency fire | |
| CN105031254A (en) | Ointment used for treating dermatitis and preparation method thereof | |
| CN111358927B (en) | Pujiang medicinal composition and application thereof | |
| WO2020024246A1 (en) | Ear drops used for tinnitus and with ear health and relief functions | |
| CN1084631C (en) | Powder medicine made of Chinese and Western medicines for treating toothache and preparation process thereof | |
| CN114392310B (en) | Anti-inflammatory antipruritic skin-moistening traditional Chinese medicine external preparation and preparation method and application thereof | |
| CN1236794C (en) | Burn treating medicine | |
| CN1058178C (en) | Cosmetics for preventing and curing acne dermatosis and its production method | |
| CN106729631A (en) | Treat the externally applied spray of intractable skin ulcer | |
| CN107617009B (en) | Compound Chinese herbal medicine external preparation for treating rabbit skin folliculitis | |
| CN1229651A (en) | Haemorrhoids powder | |
| CN105560837A (en) | Drug for treating skin injuries and preparation method thereof | |
| CN117797086A (en) | Anti-inflammatory acne-removing medicinal gel and preparation method thereof | |
| CN104906379A (en) | Traditional Chinese medicine ointment for treating bullous impetigo and preparation method of ointment | |
| CN102319343B (en) | External cream used for treating toothache caused by inflammations | |
| CN1294920C (en) | Medicine prepared with cactus and taraxacum and its prepn. process | |
| CN117085097A (en) | Traditional Chinese medicine composition for preventing and treating skin chap and traditional Chinese medicine product thereof | |
| CN111671815A (en) | A medicine with antipruritic effect, and its preparation method | |
| CN110721241A (en) | Medicine for treating chronic pharyngitis and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C19 | Lapse of patent right due to non-payment of the annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |